Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies

Fernando L. Pagan, Yasar Torres‐Yaghi, Michaeline L. Hebron, Barbara Wilmarth, R. Scott Turner, Sara Matar, Dalila Ferrante, Jaeil Ahn, Charbel Moussa

Open source

DOI: 10.1002/trc2.12296
Published: 2022-01
Container: Alzheimer's & Dementia: Translational Research & Clinical Interventions
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/trc2.12296,
  title = {Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies},
  author = {Fernando L. Pagan and Yasar Torres‐Yaghi and Michaeline L. Hebron and Barbara Wilmarth and R. Scott Turner and Sara Matar and Dalila Ferrante and Jaeil Ahn and Charbel Moussa},
  year = {2022},
  journal = {Alzheimer's \&amp; Dementia: Translational Research \&amp; Clinical Interventions},
  doi = {10.1002/trc2.12296},
  url = {https://doi.org/10.1002/trc2.12296}
}

RIS

TY  - JOUR
TI  - Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies
AU  - Fernando L. Pagan
AU  - Yasar Torres‐Yaghi
AU  - Michaeline L. Hebron
AU  - Barbara Wilmarth
AU  - R. Scott Turner
AU  - Sara Matar
AU  - Dalila Ferrante
AU  - Jaeil Ahn
AU  - Charbel Moussa
PY  - 2022
JO  - Alzheimer's &amp; Dementia: Translational Research &amp; Clinical Interventions
DO  - 10.1002/trc2.12296
UR  - https://doi.org/10.1002/trc2.12296
ER  -

APA

Pagan, F. L., Torres‐Yaghi, Y., Hebron, M. L., Wilmarth, B., Turner, R. S., Matar, S., Ferrante, D., Ahn, J., & Moussa, C. (2022). Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies. Alzheimer's & Dementia: Translational Research & Clinical Interventions. https://doi.org/10.1002/trc2.12296

Source records

crossref · retrieved 2026-11-07T07:14:44.163Z